Publications by authors named "Don Morris"

47Publications

Comparison of oral versus intravenous etoposide in the management of small-cell lung cancer; A real-world, population-based study.

Clin Respir J 2021 Jan 7;15(1):36-41. Epub 2020 Sep 7.

Department of Oncology, Tom Baker Cancer Center, University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
January 2021

Machine learning for prediction of cutaneous adverse events in patients receiving anti-PD-1 immunotherapy.

J Am Acad Dermatol 2021 Jan 22;84(1):183-185. Epub 2020 Apr 22.

Department of Oncology, University of Calgary, Ontario, Canada. Electronic address:

View Article and Find Full Text PDF
January 2021

Immune checkpoint inhibitors and non-small-cell lung cancer management: 2018 update.

Immunotherapy 2019 02;11(3):149-153

Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
February 2019

The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.

PLoS One 2018 5;13(1):e0188983. Epub 2018 Jan 5.

Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
January 2018

Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.

Blood Cancer J 2017 12 5;7(12):640. Epub 2017 Dec 5.

Department of Oncology, University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
December 2017

Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.

PLoS One 2017 4;12(8):e0181867. Epub 2017 Aug 4.

Department of Medical Oncology, Cumming School of Medicine, University of Calgary, Calgary-Alberta, Canada.

View Article and Find Full Text PDF
October 2017

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy.

Front Oncol 2017 6;7:114. Epub 2017 Jun 6.

Department of Oncology, University of Calgary, Calgary, AB, Canada.

View Article and Find Full Text PDF
June 2017

Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.

Am J Surg Pathol 2017 May;41(5):685-695

Departments of *Pathology and Laboratory Medicine, Foothill Medical Center ‡Oncology, Translational Laboratory, Tom Baker Cancer Centre ∥Oncology, University of Calgary, Calgary, AB, Canada †Department of Pathology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania §Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.

View Article and Find Full Text PDF
May 2017

PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.

PLoS One 2017 18;12(1):e0168233. Epub 2017 Jan 18.

Translation Research Laboratories, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article and Find Full Text PDF
August 2017